Sri Krishna Pharmaceuticals (SKPL)

About Sri Krishna Pharmaceuticals (SKPL)

Sri Krishna Pharmaceuticals Ltd (SKPL), established in 1974, started life as a pioneer in the bulk manufacture of acetaminophen (Paracetamol) for the domestic Indian market. Today, the company is a vertically integrated bulk manufacturer of multiple first-line-of-defence APIs, PFIs and finished dosage drugs. Paracetamol is still very important to the company and the company remains one of the largest manufacturers in the world. The role of Indian bulk drug manufacturers in the global pharma supply chain has evolved greatly, with SKPL increasing its presence in the synthesis of bulk APIs, direct compression, intermediate and finished dosage products. The SKPL R&D Centre develops medicinal products and transfers the process and analytical technology to the manufacturing site. The SKPL R&D Centre is well equipped to carryout formulation development and analytical development activities of various dosage forms such as solid oral dosage forms (tablets and capsules), Direct compressible (DC) granules and Injectables. SKPL R&D is developing the medicinal products to various countries like UK, Canada, Australia, European union